Jump to main content
Jump to site search

Issue 31, 2018
Previous Article Next Article

The unequivocal preponderance of biocomputation in clinical virology

Author affiliations

Abstract

Bioinformatics and computer based data simulation and modeling are captivating biological research, delivering great results already and promising to deliver more. As biological research is a complex, intricate, diverse field, any available support is gladly taken. With recent outbreaks and epidemics, pathogens are a constant threat to the global economy and security. Virus related plagues are somehow the most difficult to handle. Biocomputation has provided appreciable help in resolving clinical virology related issues. This review, for the first time, surveys the current status of the role of computation in virus related research. Advances made in the fields of clinical virology, antiviral drug design, viral immunology and viral oncology, through input from biocomputation, have been discussed. The amount of progress made and the software platforms available are consolidated in this review. The limitations of computation based methods are presented. Finally, the challenges facing the future of biocomputation in clinical virology are speculated upon.

Graphical abstract: The unequivocal preponderance of biocomputation in clinical virology

Back to tab navigation

Publication details

The article was received on 29 Jan 2018, accepted on 14 Mar 2018 and first published on 18 May 2018


Article type: Review Article
DOI: 10.1039/C8RA00888D
RSC Adv., 2018,8, 17334-17345
  • Open access: Creative Commons BY license
  •   Request permissions

    The unequivocal preponderance of biocomputation in clinical virology

    S. Chun, M. Muthu, J. Gopal, D. Paul, D. H. Kim, E. Gansukh and V. Anthonydhason, RSC Adv., 2018, 8, 17334
    DOI: 10.1039/C8RA00888D

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements